In a mouse model bearing chemoresistant MCF-7 breast cancer cells, injection of a murinized antigen-binding fragment targeting mouse CSF-1 retards tumor growth, enhances response to chemotherapeutic agents—including cyclophosphamide, methotrexate, and 5-FU—and prolongs survival of the mice [172]. The gene discussed is CSF1; the disease is breast carcinoma.